As reported in multiple myeloma36, the BRD of CREBBP is essential for regulating the DLBCL essential gene IRF4. Although IRF4 also exhibited essentiality in our CRISPR screen with RC-K8 cells, the BRD inhibitor CBP30 did not show efficacy. Here, IRF4 is linked to diffuse large B-cell lymphoma.